chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Atrial fibrillation, COVID-19, Cardiac arrest, Death
Clinical narrative: Narrative:  70 yo patient with PMH: CVA, T2DM, neuropathy secondary to T2DM, HTN, depression, morbid obesity, insomnia, GERD, HLP, and hearing loss was admitted for acute hypoxic respiratory failure following COVID19 positive test on 8/2/2021. Patient received both doses of Pfizer vaccine on 1/14/2021 and 2/4/2021. Patient did not use O2 at home but was started on 3L NC. His respiratory status worsened over the course of his hospitalization. e soon required non invassive positive pressure ventilation. On August 12 he was intubated due to worsening respiratory failure. Sedation was achieved with versed, propofol, and fentanyl. He received courses of remdesivir, dexamethasone, and barcitinib. There was concern for superimposed infections during his stay and he received broad spectrum antibiotics including ceftriaxone, cefepime, meropenem, and vancomycin. At times he required vasopressor support for hypotension. He also experienced sinus bradycardia as well as atrial fibrillation. A transthoracic echocardiogram was reassuring. His stay was complicated by pneumothorax and his wife declined chest tube placement. In the week prior to his death the patient had bloody airway secretions that required pRBC transfusion. He also had an episode of asystole where atropine was given. The palliative care team and the ICU team had multiple discussions with the patient's wife and son over the following days. Both agreed that the patient would not want further invasive procedures performed. The patient's wife, son, and brother visited on Aug 28 and the decision was made to withdraw care. Sedation was weaned and the patient was extubated. Time of death was 10:24am 8/28/2021.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram, Endotracheal intubation, Haemorrhage, Hypotension, Increased bronchial secretion
Clinical narrative: Narrative:  70 yo patient with PMH: CVA, T2DM, neuropathy secondary to T2DM, HTN, depression, morbid obesity, insomnia, GERD, HLP, and hearing loss was admitted for acute hypoxic respiratory failure following COVID19 positive test on 8/2/2021. Patient received both doses of Pfizer vaccine on 1/14/2021 and 2/4/2021. Patient did not use O2 at home but was started on 3L NC. His respiratory status worsened over the course of his hospitalization. e soon required non invassive positive pressure ventilation. On August 12 he was intubated due to worsening respiratory failure. Sedation was achieved with versed, propofol, and fentanyl. He received courses of remdesivir, dexamethasone, and barcitinib. There was concern for superimposed infections during his stay and he received broad spectrum antibiotics including ceftriaxone, cefepime, meropenem, and vancomycin. At times he required vasopressor support for hypotension. He also experienced sinus bradycardia as well as atrial fibrillation. A transthoracic echocardiogram was reassuring. His stay was complicated by pneumothorax and his wife declined chest tube placement. In the week prior to his death the patient had bloody airway secretions that required pRBC transfusion. He also had an episode of asystole where atropine was given. The palliative care team and the ICU team had multiple discussions with the patient's wife and son over the following days. Both agreed that the patient would not want further invasive procedures performed. The patient's wife, son, and brother visited on Aug 28 and the decision was made to withdraw care. Sedation was weaned and the patient was extubated. Time of death was 10:24am 8/28/2021.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumothorax, Positive airway pressure therapy, Red blood cell transfusion, Refusal of treatment by relative, Respiratory failure
Clinical narrative: Narrative:  70 yo patient with PMH: CVA, T2DM, neuropathy secondary to T2DM, HTN, depression, morbid obesity, insomnia, GERD, HLP, and hearing loss was admitted for acute hypoxic respiratory failure following COVID19 positive test on 8/2/2021. Patient received both doses of Pfizer vaccine on 1/14/2021 and 2/4/2021. Patient did not use O2 at home but was started on 3L NC. His respiratory status worsened over the course of his hospitalization. e soon required non invassive positive pressure ventilation. On August 12 he was intubated due to worsening respiratory failure. Sedation was achieved with versed, propofol, and fentanyl. He received courses of remdesivir, dexamethasone, and barcitinib. There was concern for superimposed infections during his stay and he received broad spectrum antibiotics including ceftriaxone, cefepime, meropenem, and vancomycin. At times he required vasopressor support for hypotension. He also experienced sinus bradycardia as well as atrial fibrillation. A transthoracic echocardiogram was reassuring. His stay was complicated by pneumothorax and his wife declined chest tube placement. In the week prior to his death the patient had bloody airway secretions that required pRBC transfusion. He also had an episode of asystole where atropine was given. The palliative care team and the ICU team had multiple discussions with the patient's wife and son over the following days. Both agreed that the patient would not want further invasive procedures performed. The patient's wife, son, and brother visited on Aug 28 and the decision was made to withdraw care. Sedation was weaned and the patient was extubated. Time of death was 10:24am 8/28/2021.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sinus bradycardia, Therapy cessation
Clinical narrative: Narrative:  70 yo patient with PMH: CVA, T2DM, neuropathy secondary to T2DM, HTN, depression, morbid obesity, insomnia, GERD, HLP, and hearing loss was admitted for acute hypoxic respiratory failure following COVID19 positive test on 8/2/2021. Patient received both doses of Pfizer vaccine on 1/14/2021 and 2/4/2021. Patient did not use O2 at home but was started on 3L NC. His respiratory status worsened over the course of his hospitalization. e soon required non invassive positive pressure ventilation. On August 12 he was intubated due to worsening respiratory failure. Sedation was achieved with versed, propofol, and fentanyl. He received courses of remdesivir, dexamethasone, and barcitinib. There was concern for superimposed infections during his stay and he received broad spectrum antibiotics including ceftriaxone, cefepime, meropenem, and vancomycin. At times he required vasopressor support for hypotension. He also experienced sinus bradycardia as well as atrial fibrillation. A transthoracic echocardiogram was reassuring. His stay was complicated by pneumothorax and his wife declined chest tube placement. In the week prior to his death the patient had bloody airway secretions that required pRBC transfusion. He also had an episode of asystole where atropine was given. The palliative care team and the ICU team had multiple discussions with the patient's wife and son over the following days. Both agreed that the patient would not want further invasive procedures performed. The patient's wife, son, and brother visited on Aug 28 and the decision was made to withdraw care. Sedation was weaned and the patient was extubated. Time of death was 10:24am 8/28/2021.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID positive hospitalization in fully vaccinated patient
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dementia, Failure to thrive, Respiratory arrest
Clinical narrative: Narrative: 84yo pt died during inpatient hospice. Death was caused by: Respiratory arrest secondary to failure to thrive to end-stage dementia per MD deah note. Pt had received covid vaccines in unknown location (not agency) on 2/2/21 & 2/23/21. Likely his death is not related given patient's advanced age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Atypical pneumonia, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chills
Clinical narrative: Narrative:  COVID-19 related hospitalization in patient who received J&J COVID vaccine. He developed COVID symptoms (body aches, fever, chills, shortness of breath) 9/28/21. Positive COVID-19 test 9/30/21. Received casirivimab/imdevimab 10/5/21. Had a reaction to monoclonal antibody therapy shortly after completing infusion with hypoxemia (not present on arrival for monoclonal antibody therapy). Admitted 10/5-10/10/21 for COVID pneumonia. Received remdesivir, dexamethasone, IV diuresis and as needed oxygen. Saturating appropriately on room air on 10/9 and became stable for discharge. Five day course of remdesivir completed. Discharged on two additional days of dexamethasone.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Hypoxia, Malaise, Pain, Pneumonia viral
Clinical narrative: Narrative:  COVID-19 related hospitalization in patient who received J&J COVID vaccine. He developed COVID symptoms (body aches, fever, chills, shortness of breath) 9/28/21. Positive COVID-19 test 9/30/21. Received casirivimab/imdevimab 10/5/21. Had a reaction to monoclonal antibody therapy shortly after completing infusion with hypoxemia (not present on arrival for monoclonal antibody therapy). Admitted 10/5-10/10/21 for COVID pneumonia. Received remdesivir, dexamethasone, IV diuresis and as needed oxygen. Saturating appropriately on room air on 10/9 and became stable for discharge. Five day course of remdesivir completed. Discharged on two additional days of dexamethasone.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID-19 related hospitalization in patient who received J&J COVID vaccine. He developed COVID symptoms (body aches, fever, chills, shortness of breath) 9/28/21. Positive COVID-19 test 9/30/21. Received casirivimab/imdevimab 10/5/21. Had a reaction to monoclonal antibody therapy shortly after completing infusion with hypoxemia (not present on arrival for monoclonal antibody therapy). Admitted 10/5-10/10/21 for COVID pneumonia. Received remdesivir, dexamethasone, IV diuresis and as needed oxygen. Saturating appropriately on room air on 10/9 and became stable for discharge. Five day course of remdesivir completed. Discharged on two additional days of dexamethasone.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Blood fibrinogen increased, Brain natriuretic peptide increased, C-reactive protein, COVID-19, Chest X-ray abnormal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/02, Pfizer dose #1 02/23, Pfizer, dose #2 09/10 Pt admit to medicine cc: "Nausea and vomiting after covid" dx: COVID-19 complicated with pneumonia and hypoxemia LOS: 3 days 09/10 COVID swab, result: detected 09/10 pt cc: exposure: unknown 09/10 CXR impression: 1. Asymmetric right lung consolidation concerning for pneumonia in the appropriate clinical setting. No significant left lung consolidation. 2. Known right upper lobe nodule reidentified. 09/10 BNP: 153.5 09/10 CRP: 7.551 09/10 DDIMER: 0.36 09/10 SARS-COV-2 Variant Sequencing result: pending 09/11 Eval: negative 09/11 DDMINER: <0.22 09/12 FIBRINOGEN: 459 09/12 DDIMER: 0.37 09/12 ESR: 58 09/13 FIBRINOGEN: 469 09/13 DDIMER: 0.25 09/13 ESR: 43 09/27 Troponin I result: 0.020 09/27 CXR impression: Interval decrease in right mid/lower lung zone airspace disease, but increase in right upper lung zone and new left midlung zone airspace disease, suggestive of multifocal pneumonia.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Hypoxia, Lung consolidation, Lung disorder, Nausea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/02, Pfizer dose #1 02/23, Pfizer, dose #2 09/10 Pt admit to medicine cc: "Nausea and vomiting after covid" dx: COVID-19 complicated with pneumonia and hypoxemia LOS: 3 days 09/10 COVID swab, result: detected 09/10 pt cc: exposure: unknown 09/10 CXR impression: 1. Asymmetric right lung consolidation concerning for pneumonia in the appropriate clinical setting. No significant left lung consolidation. 2. Known right upper lobe nodule reidentified. 09/10 BNP: 153.5 09/10 CRP: 7.551 09/10 DDIMER: 0.36 09/10 SARS-COV-2 Variant Sequencing result: pending 09/11 Eval: negative 09/11 DDMINER: <0.22 09/12 FIBRINOGEN: 459 09/12 DDIMER: 0.37 09/12 ESR: 58 09/13 FIBRINOGEN: 469 09/13 DDIMER: 0.25 09/13 ESR: 43 09/27 Troponin I result: 0.020 09/27 CXR impression: Interval decrease in right mid/lower lung zone airspace disease, but increase in right upper lung zone and new left midlung zone airspace disease, suggestive of multifocal pneumonia.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Pulmonary mass, Red blood cell sedimentation rate increased, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/02, Pfizer dose #1 02/23, Pfizer, dose #2 09/10 Pt admit to medicine cc: "Nausea and vomiting after covid" dx: COVID-19 complicated with pneumonia and hypoxemia LOS: 3 days 09/10 COVID swab, result: detected 09/10 pt cc: exposure: unknown 09/10 CXR impression: 1. Asymmetric right lung consolidation concerning for pneumonia in the appropriate clinical setting. No significant left lung consolidation. 2. Known right upper lobe nodule reidentified. 09/10 BNP: 153.5 09/10 CRP: 7.551 09/10 DDIMER: 0.36 09/10 SARS-COV-2 Variant Sequencing result: pending 09/11 Eval: negative 09/11 DDMINER: <0.22 09/12 FIBRINOGEN: 459 09/12 DDIMER: 0.37 09/12 ESR: 58 09/13 FIBRINOGEN: 469 09/13 DDIMER: 0.25 09/13 ESR: 43 09/27 Troponin I result: 0.020 09/27 CXR impression: Interval decrease in right mid/lower lung zone airspace disease, but increase in right upper lung zone and new left midlung zone airspace disease, suggestive of multifocal pneumonia.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin I normal, Vomiting
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/02, Pfizer dose #1 02/23, Pfizer, dose #2 09/10 Pt admit to medicine cc: "Nausea and vomiting after covid" dx: COVID-19 complicated with pneumonia and hypoxemia LOS: 3 days 09/10 COVID swab, result: detected 09/10 pt cc: exposure: unknown 09/10 CXR impression: 1. Asymmetric right lung consolidation concerning for pneumonia in the appropriate clinical setting. No significant left lung consolidation. 2. Known right upper lobe nodule reidentified. 09/10 BNP: 153.5 09/10 CRP: 7.551 09/10 DDIMER: 0.36 09/10 SARS-COV-2 Variant Sequencing result: pending 09/11 Eval: negative 09/11 DDMINER: <0.22 09/12 FIBRINOGEN: 459 09/12 DDIMER: 0.37 09/12 ESR: 58 09/13 FIBRINOGEN: 469 09/13 DDIMER: 0.25 09/13 ESR: 43 09/27 Troponin I result: 0.020 09/27 CXR impression: Interval decrease in right mid/lower lung zone airspace disease, but increase in right upper lung zone and new left midlung zone airspace disease, suggestive of multifocal pneumonia.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary normal, Atelectasis, Blood bicarbonate normal, Blood fibrinogen normal, Blood gases
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/07, MODERNA, dose #1 02/04, MODERNA dose #2 08/29 SARS-COV-2 Variant Sequencing RESULT: pending 08/29 COVID swab, result: detected 08/30 pt cc:body aches and burning lungs exposure: unknown 08/30 ESR 7 08/30 LDH 256.8 08/30 CTA PE Impression: 1. No pulmonary embolism, pneumothorax, aortic aneurysm or dissection. No focal airspace consolidation. 2. Bilateral axillary lymph nodes which are fatty replaced in the hilum and may be related to prior treatment for lymphoma. Prominent left axillary lymph node which is present on comparison study dated 6/18/2021 and was likely the lymph node biopsied on 7/26/2021. Otherwise, no mediastinal adenopathy 08/30 CXR impression: Bibasilar atelectasis. 08/30 FERRITI 509.7 08/30 CRP 0.349 08/30 pt admit to medicine cc: body aches and "burning lungs" dx: Covid pneumonia LOS: 2 days 08/30 PT/INR 11.6/1.4 08/30 ABG: result: i-pH 7.39, i-PC02 39.6, i-P02 72, i-HCO3 24.0 09/01 FIBRINOGEN: 212 09/01 DDIMER: 0.27 09/01 ESR 2 09/02 FIBRINOGEN: 177 09/02 DDIMER: 0.30 09/02 ESR <1 09/26 COVID swab, result: not detected
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactate dehydrogenase increased, Blood pH normal, Burning sensation, C-reactive protein normal, COVID-19
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/07, MODERNA, dose #1 02/04, MODERNA dose #2 08/29 SARS-COV-2 Variant Sequencing RESULT: pending 08/29 COVID swab, result: detected 08/30 pt cc:body aches and burning lungs exposure: unknown 08/30 ESR 7 08/30 LDH 256.8 08/30 CTA PE Impression: 1. No pulmonary embolism, pneumothorax, aortic aneurysm or dissection. No focal airspace consolidation. 2. Bilateral axillary lymph nodes which are fatty replaced in the hilum and may be related to prior treatment for lymphoma. Prominent left axillary lymph node which is present on comparison study dated 6/18/2021 and was likely the lymph node biopsied on 7/26/2021. Otherwise, no mediastinal adenopathy 08/30 CXR impression: Bibasilar atelectasis. 08/30 FERRITI 509.7 08/30 CRP 0.349 08/30 pt admit to medicine cc: body aches and "burning lungs" dx: Covid pneumonia LOS: 2 days 08/30 PT/INR 11.6/1.4 08/30 ABG: result: i-pH 7.39, i-PC02 39.6, i-P02 72, i-HCO3 24.0 09/01 FIBRINOGEN: 212 09/01 DDIMER: 0.27 09/01 ESR 2 09/02 FIBRINOGEN: 177 09/02 DDIMER: 0.30 09/02 ESR <1 09/26 COVID swab, result: not detected
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Fibrin D dimer normal, International normalised ratio normal, PCO2 normal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/07, MODERNA, dose #1 02/04, MODERNA dose #2 08/29 SARS-COV-2 Variant Sequencing RESULT: pending 08/29 COVID swab, result: detected 08/30 pt cc:body aches and burning lungs exposure: unknown 08/30 ESR 7 08/30 LDH 256.8 08/30 CTA PE Impression: 1. No pulmonary embolism, pneumothorax, aortic aneurysm or dissection. No focal airspace consolidation. 2. Bilateral axillary lymph nodes which are fatty replaced in the hilum and may be related to prior treatment for lymphoma. Prominent left axillary lymph node which is present on comparison study dated 6/18/2021 and was likely the lymph node biopsied on 7/26/2021. Otherwise, no mediastinal adenopathy 08/30 CXR impression: Bibasilar atelectasis. 08/30 FERRITI 509.7 08/30 CRP 0.349 08/30 pt admit to medicine cc: body aches and "burning lungs" dx: Covid pneumonia LOS: 2 days 08/30 PT/INR 11.6/1.4 08/30 ABG: result: i-pH 7.39, i-PC02 39.6, i-P02 72, i-HCO3 24.0 09/01 FIBRINOGEN: 212 09/01 DDIMER: 0.27 09/01 ESR 2 09/02 FIBRINOGEN: 177 09/02 DDIMER: 0.30 09/02 ESR <1 09/26 COVID swab, result: not detected
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: PO2 decreased, Pain, Prothrombin time normal, Red blood cell sedimentation rate normal, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/07, MODERNA, dose #1 02/04, MODERNA dose #2 08/29 SARS-COV-2 Variant Sequencing RESULT: pending 08/29 COVID swab, result: detected 08/30 pt cc:body aches and burning lungs exposure: unknown 08/30 ESR 7 08/30 LDH 256.8 08/30 CTA PE Impression: 1. No pulmonary embolism, pneumothorax, aortic aneurysm or dissection. No focal airspace consolidation. 2. Bilateral axillary lymph nodes which are fatty replaced in the hilum and may be related to prior treatment for lymphoma. Prominent left axillary lymph node which is present on comparison study dated 6/18/2021 and was likely the lymph node biopsied on 7/26/2021. Otherwise, no mediastinal adenopathy 08/30 CXR impression: Bibasilar atelectasis. 08/30 FERRITI 509.7 08/30 CRP 0.349 08/30 pt admit to medicine cc: body aches and "burning lungs" dx: Covid pneumonia LOS: 2 days 08/30 PT/INR 11.6/1.4 08/30 ABG: result: i-pH 7.39, i-PC02 39.6, i-P02 72, i-HCO3 24.0 09/01 FIBRINOGEN: 212 09/01 DDIMER: 0.27 09/01 ESR 2 09/02 FIBRINOGEN: 177 09/02 DDIMER: 0.30 09/02 ESR <1 09/26 COVID swab, result: not detected
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Serum ferritin increased
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/07, MODERNA, dose #1 02/04, MODERNA dose #2 08/29 SARS-COV-2 Variant Sequencing RESULT: pending 08/29 COVID swab, result: detected 08/30 pt cc:body aches and burning lungs exposure: unknown 08/30 ESR 7 08/30 LDH 256.8 08/30 CTA PE Impression: 1. No pulmonary embolism, pneumothorax, aortic aneurysm or dissection. No focal airspace consolidation. 2. Bilateral axillary lymph nodes which are fatty replaced in the hilum and may be related to prior treatment for lymphoma. Prominent left axillary lymph node which is present on comparison study dated 6/18/2021 and was likely the lymph node biopsied on 7/26/2021. Otherwise, no mediastinal adenopathy 08/30 CXR impression: Bibasilar atelectasis. 08/30 FERRITI 509.7 08/30 CRP 0.349 08/30 pt admit to medicine cc: body aches and "burning lungs" dx: Covid pneumonia LOS: 2 days 08/30 PT/INR 11.6/1.4 08/30 ABG: result: i-pH 7.39, i-PC02 39.6, i-P02 72, i-HCO3 24.0 09/01 FIBRINOGEN: 212 09/01 DDIMER: 0.27 09/01 ESR 2 09/02 FIBRINOGEN: 177 09/02 DDIMER: 0.30 09/02 ESR <1 09/26 COVID swab, result: not detected
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Blood fibrinogen, C-reactive protein increased, COVID-19, Chest X-ray normal, Diabetic gastroparesis
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/26, Pfizer dose #1 03/19, Pfizer dose #2 09/11 CXR Impression: No focal airspace consolidation. 09/11 COVID swab, result: detected 09/11 pt cc: exposure: unknown 09/11 PT/INR 13.3/1.19 09/11 DDIMER: 0.93 09/11 CRP: 0.175 09/11 pt admit to medicine cc: N/V, po intolerance dx: recurrent hyperemesis likely secundary to diabetic gastroparesis and asymptomatic COVID-19 infection (no PNA/pneumonitis) LOS: 4 days 09/12 FIBRINOGEN: 317 09/12 DDIMER: 0.73 09/12 ESR: 39 09/13 FIBRINOGEN: 312 09/13 DDIMER: 0.44 09/13 ESR: 45 09/14 FIBRINOGEN: 304 09/14 DDIMER: 0.46 09/14 ESR: 39 10/08 COVID swab, result: NOT detected 10/09 CXR impression: No acute cardiopulmonary abnormality 10/26 COVID swab, result: NOT detected
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, International normalised ratio increased, Prothrombin time prolonged, Red blood cell sedimentation rate increased, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/26, Pfizer dose #1 03/19, Pfizer dose #2 09/11 CXR Impression: No focal airspace consolidation. 09/11 COVID swab, result: detected 09/11 pt cc: exposure: unknown 09/11 PT/INR 13.3/1.19 09/11 DDIMER: 0.93 09/11 CRP: 0.175 09/11 pt admit to medicine cc: N/V, po intolerance dx: recurrent hyperemesis likely secundary to diabetic gastroparesis and asymptomatic COVID-19 infection (no PNA/pneumonitis) LOS: 4 days 09/12 FIBRINOGEN: 317 09/12 DDIMER: 0.73 09/12 ESR: 39 09/13 FIBRINOGEN: 312 09/13 DDIMER: 0.44 09/13 ESR: 45 09/14 FIBRINOGEN: 304 09/14 DDIMER: 0.46 09/14 ESR: 39 10/08 COVID swab, result: NOT detected 10/09 CXR impression: No acute cardiopulmonary abnormality 10/26 COVID swab, result: NOT detected
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/26, Pfizer dose #1 03/19, Pfizer dose #2 09/11 CXR Impression: No focal airspace consolidation. 09/11 COVID swab, result: detected 09/11 pt cc: exposure: unknown 09/11 PT/INR 13.3/1.19 09/11 DDIMER: 0.93 09/11 CRP: 0.175 09/11 pt admit to medicine cc: N/V, po intolerance dx: recurrent hyperemesis likely secundary to diabetic gastroparesis and asymptomatic COVID-19 infection (no PNA/pneumonitis) LOS: 4 days 09/12 FIBRINOGEN: 317 09/12 DDIMER: 0.73 09/12 ESR: 39 09/13 FIBRINOGEN: 312 09/13 DDIMER: 0.44 09/13 ESR: 45 09/14 FIBRINOGEN: 304 09/14 DDIMER: 0.46 09/14 ESR: 39 10/08 COVID swab, result: NOT detected 10/09 CXR impression: No acute cardiopulmonary abnormality 10/26 COVID swab, result: NOT detected
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  On 9/22/21 patient's family contacted SW for help with pt due to pt requiring more care then family could provide at home. Patient is a 89 yr. old. Patient is followed medically at the clinic and has a diagnosis h/o cad, htn, PAF, hyperlipidemia, stable pulmonary nodules, phtn on chest ct, thyroid nodules, RA, (B) carotid stenosis, TAA, AAA, benign (R) adrenal adenoma, (B) hip pain, (R) knee djd, gerd/esophagitis/esophageal stricture (s/p dilatation)/gastriti, chronic constipation, diverticulosis, h/o tubulovillous/tubular adenoma/hyperplastic colon polyps, iron def anemia, bph/nocturia, (L) renal cyst, depression, dermatitis and rhinitis. On 9/26/21 pt passed away. No information provided regarding circumstances of pt's death. Pt had received covid vaccine on 1/12 & 2/9. Likely this death is not related to covid vaccines given patient's advanced age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Arteriogram coronary normal, Cardiac failure, Cardiac failure congestive, Cardiac imaging procedure abnormal, Cardiac index decreased
Clinical narrative: Narrative:  This is a 41 y/o mail with pmhx sig for HTN, HLD and obesity. He initially had chest pain similar to this back in September a few days after his second COVID vaccine. The pain went away after several days. However for the past 2 weeks, he had noticed a recurrence of his symptoms associated with vomiting. His CXR back in September showed a normal cardiac silhouette; however repeat CXR here shows cardiomegaly. EKG with sinus tachycardia and TW inversions in the inferior/lateral leads. His symptoms appeared to suggest gastrointestinal initially. Primary team started treatment for pericarditis. EKG with inferior/lateral TWI's, which could be consistent with stage III. Echocardiogram now with LVEF < 20% with severe LV dilation, which has never been diagnosed previously. RHC obtained 10/28 with severely low cardiac index (1.8), elevated PCW 33, elevated RA pressure 20. Coronary angiogram was normal on 10/28. CMR was obtained to define etiology did not show evidence of pericardial enhancement or late gadolinium enhancement to suggest scar or myocarditis. Biventricular failure noted on MRI. # Non-ischemic cardiomyopathy with low cardiac output # Biventricular heart failure # Concern for previous myocarditis possibly 2/2 to COVID vaccine--------------------------------------------------------------------------------------------------------------------------------------------------------On admission, the patient reported burning chest pain that occured following the 2nd dose of the Pfizer COVID vaccine which he recieved on Sep. 13th. His was intermittent in nature and resolved spontaneously after 5 days, but recurred on Oct. 12 and persisted until his admission to MC. He was found to have pericardial fluid on CTPE in the ED concerning for possible post-vaccination pericarditis/myocarditis, and the patient was started on Ibuprofen for treatment. It was later discovered by ECHO that the patient's EF was noted to be ~ 20-25% consistent with new heart failure. The only identifiable risk factor for the patient's clinical condition was recent administration of the COVID vaccine.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac output decreased, Cardiomegaly, Cardiomyopathy, Catheterisation cardiac abnormal, Chest X-ray abnormal
Clinical narrative: Narrative:  This is a 41 y/o mail with pmhx sig for HTN, HLD and obesity. He initially had chest pain similar to this back in September a few days after his second COVID vaccine. The pain went away after several days. However for the past 2 weeks, he had noticed a recurrence of his symptoms associated with vomiting. His CXR back in September showed a normal cardiac silhouette; however repeat CXR here shows cardiomegaly. EKG with sinus tachycardia and TW inversions in the inferior/lateral leads. His symptoms appeared to suggest gastrointestinal initially. Primary team started treatment for pericarditis. EKG with inferior/lateral TWI's, which could be consistent with stage III. Echocardiogram now with LVEF < 20% with severe LV dilation, which has never been diagnosed previously. RHC obtained 10/28 with severely low cardiac index (1.8), elevated PCW 33, elevated RA pressure 20. Coronary angiogram was normal on 10/28. CMR was obtained to define etiology did not show evidence of pericardial enhancement or late gadolinium enhancement to suggest scar or myocarditis. Biventricular failure noted on MRI. # Non-ischemic cardiomyopathy with low cardiac output # Biventricular heart failure # Concern for previous myocarditis possibly 2/2 to COVID vaccine--------------------------------------------------------------------------------------------------------------------------------------------------------On admission, the patient reported burning chest pain that occured following the 2nd dose of the Pfizer COVID vaccine which he recieved on Sep. 13th. His was intermittent in nature and resolved spontaneously after 5 days, but recurred on Oct. 12 and persisted until his admission to MC. He was found to have pericardial fluid on CTPE in the ED concerning for possible post-vaccination pericarditis/myocarditis, and the patient was started on Ibuprofen for treatment. It was later discovered by ECHO that the patient's EF was noted to be ~ 20-25% consistent with new heart failure. The only identifiable risk factor for the patient's clinical condition was recent administration of the COVID vaccine.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Computerised tomogram thorax abnormal, Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram T wave inversion
Clinical narrative: Narrative:  This is a 41 y/o mail with pmhx sig for HTN, HLD and obesity. He initially had chest pain similar to this back in September a few days after his second COVID vaccine. The pain went away after several days. However for the past 2 weeks, he had noticed a recurrence of his symptoms associated with vomiting. His CXR back in September showed a normal cardiac silhouette; however repeat CXR here shows cardiomegaly. EKG with sinus tachycardia and TW inversions in the inferior/lateral leads. His symptoms appeared to suggest gastrointestinal initially. Primary team started treatment for pericarditis. EKG with inferior/lateral TWI's, which could be consistent with stage III. Echocardiogram now with LVEF < 20% with severe LV dilation, which has never been diagnosed previously. RHC obtained 10/28 with severely low cardiac index (1.8), elevated PCW 33, elevated RA pressure 20. Coronary angiogram was normal on 10/28. CMR was obtained to define etiology did not show evidence of pericardial enhancement or late gadolinium enhancement to suggest scar or myocarditis. Biventricular failure noted on MRI. # Non-ischemic cardiomyopathy with low cardiac output # Biventricular heart failure # Concern for previous myocarditis possibly 2/2 to COVID vaccine--------------------------------------------------------------------------------------------------------------------------------------------------------On admission, the patient reported burning chest pain that occured following the 2nd dose of the Pfizer COVID vaccine which he recieved on Sep. 13th. His was intermittent in nature and resolved spontaneously after 5 days, but recurred on Oct. 12 and persisted until his admission to MC. He was found to have pericardial fluid on CTPE in the ED concerning for possible post-vaccination pericarditis/myocarditis, and the patient was started on Ibuprofen for treatment. It was later discovered by ECHO that the patient's EF was noted to be ~ 20-25% consistent with new heart failure. The only identifiable risk factor for the patient's clinical condition was recent administration of the COVID vaccine.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Gastrointestinal disorder, Left ventricular dilatation, Pericardial effusion, Pericarditis
Clinical narrative: Narrative:  This is a 41 y/o mail with pmhx sig for HTN, HLD and obesity. He initially had chest pain similar to this back in September a few days after his second COVID vaccine. The pain went away after several days. However for the past 2 weeks, he had noticed a recurrence of his symptoms associated with vomiting. His CXR back in September showed a normal cardiac silhouette; however repeat CXR here shows cardiomegaly. EKG with sinus tachycardia and TW inversions in the inferior/lateral leads. His symptoms appeared to suggest gastrointestinal initially. Primary team started treatment for pericarditis. EKG with inferior/lateral TWI's, which could be consistent with stage III. Echocardiogram now with LVEF < 20% with severe LV dilation, which has never been diagnosed previously. RHC obtained 10/28 with severely low cardiac index (1.8), elevated PCW 33, elevated RA pressure 20. Coronary angiogram was normal on 10/28. CMR was obtained to define etiology did not show evidence of pericardial enhancement or late gadolinium enhancement to suggest scar or myocarditis. Biventricular failure noted on MRI. # Non-ischemic cardiomyopathy with low cardiac output # Biventricular heart failure # Concern for previous myocarditis possibly 2/2 to COVID vaccine--------------------------------------------------------------------------------------------------------------------------------------------------------On admission, the patient reported burning chest pain that occured following the 2nd dose of the Pfizer COVID vaccine which he recieved on Sep. 13th. His was intermittent in nature and resolved spontaneously after 5 days, but recurred on Oct. 12 and persisted until his admission to MC. He was found to have pericardial fluid on CTPE in the ED concerning for possible post-vaccination pericarditis/myocarditis, and the patient was started on Ibuprofen for treatment. It was later discovered by ECHO that the patient's EF was noted to be ~ 20-25% consistent with new heart failure. The only identifiable risk factor for the patient's clinical condition was recent administration of the COVID vaccine.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary arterial wedge pressure increased, Right atrial pressure increased, Sinus tachycardia, Symptom recurrence, Vomiting
Clinical narrative: Narrative:  This is a 41 y/o mail with pmhx sig for HTN, HLD and obesity. He initially had chest pain similar to this back in September a few days after his second COVID vaccine. The pain went away after several days. However for the past 2 weeks, he had noticed a recurrence of his symptoms associated with vomiting. His CXR back in September showed a normal cardiac silhouette; however repeat CXR here shows cardiomegaly. EKG with sinus tachycardia and TW inversions in the inferior/lateral leads. His symptoms appeared to suggest gastrointestinal initially. Primary team started treatment for pericarditis. EKG with inferior/lateral TWI's, which could be consistent with stage III. Echocardiogram now with LVEF < 20% with severe LV dilation, which has never been diagnosed previously. RHC obtained 10/28 with severely low cardiac index (1.8), elevated PCW 33, elevated RA pressure 20. Coronary angiogram was normal on 10/28. CMR was obtained to define etiology did not show evidence of pericardial enhancement or late gadolinium enhancement to suggest scar or myocarditis. Biventricular failure noted on MRI. # Non-ischemic cardiomyopathy with low cardiac output # Biventricular heart failure # Concern for previous myocarditis possibly 2/2 to COVID vaccine--------------------------------------------------------------------------------------------------------------------------------------------------------On admission, the patient reported burning chest pain that occured following the 2nd dose of the Pfizer COVID vaccine which he recieved on Sep. 13th. His was intermittent in nature and resolved spontaneously after 5 days, but recurred on Oct. 12 and persisted until his admission to MC. He was found to have pericardial fluid on CTPE in the ED concerning for possible post-vaccination pericarditis/myocarditis, and the patient was started on Ibuprofen for treatment. It was later discovered by ECHO that the patient's EF was noted to be ~ 20-25% consistent with new heart failure. The only identifiable risk factor for the patient's clinical condition was recent administration of the COVID vaccine.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Death
Clinical narrative: Narrative: 80yo patient passed away on 9/25/2021 at grandson's wedding. EMS was called and pt was taken to hospital where he lived for several hours but ultimately passed away from Sudden Cardiac Arrest. Pt had received covid vaccine on 1/22/21 & 2/22/21. Likely this death is not related to covid vaccines given patient's age, cardiac arrest death, and long length of time between date of vaccines and date of death.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Hepatic cancer
Clinical narrative: Narrative:  62yo male patient died at outside agency hospital from Carcinomas of liver on 9/30/2021 in acute inpatient care at hospital. Pt present to hospital on 9/27/21. Pt had received vaccines on 3/11/21 & 4/9/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Condition aggravated, Death, Fall, Hepatic cirrhosis
Clinical narrative: Narrative: 71 yo male with PMHx of HCC (liver cancer), spinal stenosis of lumbar region, Mood disorder, PTSD, recurrent major depression in partial remission, COPD, HLD, CAD, DM, H/o ETOH dependence, esophageal varices due to cirrhosis, HCV, who was enrolled in home hospice, presented to the ED via EMS on 09/30/21 d/t melena and weakness after a fall. Patient was recently admitted to MC from d/t 9/17 to 9/18/21 d/t Decompensated Cirrhosis due to HCC. He was discharged home on 9/18/21 with home hospice. Pt died at home in hospice care on 10/01/2021. Death was caused by: HCC stage IV. Pt had receive 3 covid vaccines on 2/2/21, 3/2/21, 8/31/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and length of time between date of vaccines and date of death.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Hepatocellular carcinoma, Melaena
Clinical narrative: Narrative: 71 yo male with PMHx of HCC (liver cancer), spinal stenosis of lumbar region, Mood disorder, PTSD, recurrent major depression in partial remission, COPD, HLD, CAD, DM, H/o ETOH dependence, esophageal varices due to cirrhosis, HCV, who was enrolled in home hospice, presented to the ED via EMS on 09/30/21 d/t melena and weakness after a fall. Patient was recently admitted to MC from d/t 9/17 to 9/18/21 d/t Decompensated Cirrhosis due to HCC. He was discharged home on 9/18/21 with home hospice. Pt died at home in hospice care on 10/01/2021. Death was caused by: HCC stage IV. Pt had receive 3 covid vaccines on 2/2/21, 3/2/21, 8/31/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and length of time between date of vaccines and date of death.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 89yo male patient residing in NH - (non-agency) died on 8/26/21. Pt with CHF & decompensated cirrhosis. Pt had received covid vaccines on 1/13/21 & 2/10/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, COVID-19, Cardiac failure congestive, Chills, Death
Clinical narrative: Narrative: Breakthrough COVID case. Pt had COVID confirmed non-facility, test was done 9/14. Sx on 9/17 included altered mentation, delirium, hypoxia, chills, temp elevated 1 degree from baseline (per PCP not technically a fever). Monoclonal infusion 9/16 at 1:30 pm. EMS called to take pt to non-facility hospital 9/17 and husband confirmed that patient had passed away Sept. 17th of CHF.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Delirium, Hypoxia, Mental status changes, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Narrative: Breakthrough COVID case. Pt had COVID confirmed non-facility, test was done 9/14. Sx on 9/17 included altered mentation, delirium, hypoxia, chills, temp elevated 1 degree from baseline (per PCP not technically a fever). Monoclonal infusion 9/16 at 1:30 pm. EMS called to take pt to non-facility hospital 9/17 and husband confirmed that patient had passed away Sept. 17th of CHF.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 86yo male died on 9/24/2021 at home. No information in agency records. Pt did see multiple other providers outside of agency. Pt had received covid vaccines on 1/14/2021 & 2/11/2021. Likely his death is not related to covid vaccines given patient's advanced age and long length of time between date of vaccines and date of death.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 46yo pt died on 09/26/2021. Pt had received covid vaccines on 5/5/21 & 6/4/21. No information in agency records regarding pt's death. Not able to assess if death is related to vaccines.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient admitted to hospice care and dies shortly thereafter. Patient was 87 years old with multiple medical diagnoses.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Device dislocation, Intensive care, Janus kinase 2 mutation, Myeloproliferative neoplasm
Clinical narrative: Narrative: 83yo male patient died on 9/9/2021 in ICU at non-agency hospital transferred from nursing home under agency contract. Pt had underwent surgery on 8/11/21 for dislocation of left artificial hip. Pt also under agency hemetology care for myeloproliferative neoplasmJAK2 positive. Pt also developed renal impairment prior to death. Pt had received covid vaccines on 1/26/21 & 2/23/21. This death is likely not related to the vaccinations due to comorbidities, ager, and length of time from vaccine administration.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Renal impairment, Surgery
Clinical narrative: Narrative: 83yo male patient died on 9/9/2021 in ICU at non-agency hospital transferred from nursing home under agency contract. Pt had underwent surgery on 8/11/21 for dislocation of left artificial hip. Pt also under agency hemetology care for myeloproliferative neoplasmJAK2 positive. Pt also developed renal impairment prior to death. Pt had received covid vaccines on 1/26/21 & 2/23/21. This death is likely not related to the vaccinations due to comorbidities, ager, and length of time from vaccine administration.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Death, Dementia, Hyponatraemia, Pneumonia
Clinical narrative: Narrative: 91 yo pt with recent hospitalization from non-agency hospital died on 9/27/21. Pt was discharged on 9/2/21 from community with the following diagnosis: acute CHF, streptococcal sepsis w/ pneumonia, hyponatremia, dementia, urinary retention, Pt had received covid vaccines on 1/14/21 & 2/12/21. Likely his death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Streptococcal sepsis, Urinary retention
Clinical narrative: Narrative: 91 yo pt with recent hospitalization from non-agency hospital died on 9/27/21. Pt was discharged on 9/2/21 from community with the following diagnosis: acute CHF, streptococcal sepsis w/ pneumonia, hyponatremia, dementia, urinary retention, Pt had received covid vaccines on 1/14/21 & 2/12/21. Likely his death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  70yo male patient died on 9/8/21 at Hospital (non-agency hospital). Pt with the following medical history: PAST MEDICAL ischemic colitis contributing to hypotension and syncope CAD s/p 4v CABG on Aug 28/2011, PCI in 1995 ICM (last EF of 35% in Aug 2011, 52% on last TTE) PAF HTN PTSD h/o Hep C (txd) GERD # ED. #BL cerumen parital impaction w/ itching and irritation. # RIGHT lower leg dermatitis. PAST SURGICAL Left eye blindness 2/2 shrapnel Right low leg 2/2 osteomyelitis Right palmar hand Pt had covid vaccines on 2/23/21 & 3/16/2021. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 88yo male patient dieed on 5/11/2021. No information available regarding pt's death outside of agency facilities. Pt with Hx of AFIB and CAD followed by outside Mds. Pt had received covid vaccine (J&J) on 5/11/2021. Not able to assess if death related to covid vaccine but likely not related to the vaccinations due to pt's advanced age and length of time from vaccine administration.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 51yo mlae patient died outside facilities on 5/29/2021. Pt with medical history of obesity, smoker, htn, h/o multiple recurrent nephrolithiasis, right renal hematoma, chronic lbp, osa, erectile dysfunction, t2dm. No information provided regarding pt's death. Not able to assess if death related to covid vaccines or not.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Blood fibrinogen increased, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Cough
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/11/2020 COVID swab, result: not detected 05/12 CXR impression: No Acute cardiopulmonary abnormality 01/07, Pfizer, dose #1 (NON-FACILITY) 01/28, Pfizer, dose #2 (NON-FACILITY) 08/12 pt cc: cough, fatigue, fever, dyspnea, exposure: unknown 08/22 COVID swab, result: detected 08/22 pt admit to medicine cc: shortness of breath dx: COVID-19 Pneumonia LOS: 7 days 08/22 CXR impression: interval development of bilateral airspace opacities. 08/22 FIBRINOGEN result: 480 08/22 DDIMER result: 6.08 08/22 SARS-COV-2 Variant Sequencing result: pending 08/22 FERRITIN result: 369.8 08/23 https://portal.vaers.org/rsa/intranet/images4/2023/3/2601587P_138f238e-4870-401c-ab59-856a11c1a193.jpgFIBRINOGEN result: 391 08/23 ESR result: 33 08/23 DDIMER result: 5.89 08/24 FIBRINOGEN result: 391 08/24 DDIMER result: 3.52 08/27 ESR result: 5 08/28 FIBRINOGEN result: 179 08/28 DDIMER result: 2.20 08/28 ESR result: <1 08/29 FIBRINOGEN result: 156 08/29 DDIMER result: 1.82 08/29 ESR 1
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Fibrin D dimer, Lung opacity, Pyrexia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/11/2020 COVID swab, result: not detected 05/12 CXR impression: No Acute cardiopulmonary abnormality 01/07, Pfizer, dose #1 (NON-FACILITY) 01/28, Pfizer, dose #2 (NON-FACILITY) 08/12 pt cc: cough, fatigue, fever, dyspnea, exposure: unknown 08/22 COVID swab, result: detected 08/22 pt admit to medicine cc: shortness of breath dx: COVID-19 Pneumonia LOS: 7 days 08/22 CXR impression: interval development of bilateral airspace opacities. 08/22 FIBRINOGEN result: 480 08/22 DDIMER result: 6.08 08/22 SARS-COV-2 Variant Sequencing result: pending 08/22 FERRITIN result: 369.8 08/23 https://portal.vaers.org/rsa/intranet/images4/2023/3/2601587P_138f238e-4870-401c-ab59-856a11c1a193.jpgFIBRINOGEN result: 391 08/23 ESR result: 33 08/23 DDIMER result: 5.89 08/24 FIBRINOGEN result: 391 08/24 DDIMER result: 3.52 08/27 ESR result: 5 08/28 FIBRINOGEN result: 179 08/28 DDIMER result: 2.20 08/28 ESR result: <1 08/29 FIBRINOGEN result: 156 08/29 DDIMER result: 1.82 08/29 ESR 1